Skip to main content
Log in

Economic burden of MRSA-related NP substantial

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Patel D, et al. Direct Medical Costs Associated with Methicillin-resistant Staphylococcus Aureus Related Nosocomial Pneumonia in the U.S. 50th Annual Meeting of the Infectious Diseases Society of America : (plus poster) abstr. 1565, 17 Oct 2012.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Economic burden of MRSA-related NP substantial. PharmacoEconomics & Outcomes News 668, 5 (2012). https://doi.org/10.1007/s40274-012-0013-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-012-0013-y

Navigation